December 2024 – Page 3

Belapectin Shows Promising Reduction in Esophageal Varices in MASH Cirrhosis Patients, Despite Missing Primary Endpoint

6 months ago talkbio0Tagged belapectin, Clinical Trials, Esophageal Varices, Galactose Binding Lectin, Liver Cirrhosis, MASH, Portal Hypertension

Belapectin, MASH Cirrhosis, Portal Hypertension, Esophageal Varices, Clinical Trial, Galectin Therapeutics

Novo Nordisk’s CagriSema Falls Short of Weight Loss Expectations, Highlighting High Investor Expectations

6 months ago talkbio0Tagged CagriSema, Expectations, investor, Nordisk, Obesity, REDEFINE 1 trial, Weight-Loss Agents

CagriSema, Novo Nordisk, Weight Loss Drugs, REDEFINE 1 Trial, Obesity Treatment, Investor Expectations

Applied Therapeutics Undergoes Leadership Changes Amid FDA Rejection and Regulatory Challenges

6 months ago talkbio0Tagged Changing, disease drug, Govorestat, Leadership, regulatory, Rejection, United States Food and Drug Administration

Applied Therapeutics, leadership changes, FDA rejection, rare disease drug, govorestat, regulatory challenges

Pfizer Transfers Global Creative Duties to Publicis in Strategic Marketing Shift

6 months ago talkbio0Tagged Drug Industry, Pfizer, Publicis

Pfizer, Publicis, global creative duties, marketing strategy, pharmaceutical industry

Biopharmaceutical Manufacturing and Emerging Trends in 2024: A Global Outlook

6 months ago talkbio0Tagged 2024, Biopharmaceutical manufacturing, Biosimilars, Biotechnology, Cells, Drug Discovery, gene therapy, innovations, Precision Medicine, trends qualifier

Biopharmaceutical manufacturing, 2024 trends, personalized medicine, AI-driven drug discovery, biosimilars, cell and gene therapies, biotechnology innovations.

Breakthrough in Familial Chylomicronemia Syndrome: FDA Approves Ionis’ Tryngolza as First Treatment

6 months ago talkbio0Tagged Approved, Familial chylomicronemia syndrome, Genetic Hyperlipidemia, Lipid-lowering therapy, Pancreatitis, Acute, TRYNGOLZA, United States Food and Drug Administration

Familial Chylomicronemia Syndrome (FCS), Ionis Tryngolza, FDA Approval, Rare Genetic Hyperlipidemia, Acute Pancreatitis, Lipid-Lowering Therapy

GSK Reports Mixed Results for Jemperli/Zejula Combination in First-Line Ovarian Cancer Trial

6 months ago talkbio0Tagged Clinical Trials, first-line, Jemperli, mixed survival data, ovarian neoplasm, SmithKline Beecham, Zejula

GSK, Jemperli, Zejula, ovarian cancer, first-line treatment, mixed survival data, clinical trial results

Rhythm Pharmaceuticals Secures Expanded FDA Approval for IMCIVREE to Treat Genetic Obesity in Children as Young as 2 Years Old

6 months ago talkbio0Tagged Approved, Bardet-Biedl Syndrome, Genetic obesity, Imcivree, leptin receptor, human, Obesity, PCSK1 gene, Pediatric brand name, POMC, Rhythm, setmelanotide, United States Food and Drug Administration

Rhythm Pharmaceuticals, IMCIVREE, setmelanotide, FDA approval, genetic obesity, Bardet-Biedl syndrome, POMC, PCSK1, LEPR deficiency, pediatric obesity treatment